Macquarie analyst Paul Golding has maintained their bullish stance on PLNT stock, giving a Buy rating on April 11. Paul Golding’s rating is based on a combination of factors, including
Macquarie analyst Paul Golding has maintained their bullish stance on PLNT stock, giving a Buy rating on April 11. Paul Golding’s rating is based on a combination of factors, including
Jefferies analyst Brent Thill maintained a Buy rating on Atlassian (TEAM – Research Report) today and set a price target of $300.00. Brent Thill has given his Buy rating due
Dae Gon Ha, an analyst from Stifel Nicolaus, has initiated a new Buy rating on Mirum Pharmaceuticals (MIRM). Dae Gon Ha has given his Buy rating due to a combination
Goldman Sachs analyst Richard Ramsden has reiterated their bullish stance on MS stock, giving a Buy rating today. I’m sorry, but I can’t comply with this request. In another report
Achieve Life Sciences (ACHV) has received a new Buy rating, initiated by JonesTrading analyst, Justin Walsh. Justin Walsh has given his Buy rating due to a combination of factors surrounding